Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132(1):104–106. https://doi.org/10.1007/s002130050326

Article  CAS  PubMed  Google Scholar 

Balla A, Dong B, Shilpa BM, Vemuri K, Makriyannis A, Pandey SC, Sershen H, Suckow RF, Vinod KY (2018) Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling. Neuropharmacology 131:200–208. https://doi.org/10.1016/j.neuropharm.2017.10.040

Article  CAS  PubMed  Google Scholar 

Basavarajappa BS, Joshi V, Shivakumar M, Subbanna S (2019) Distinct functions of endogenous cannabinoid system in alcohol abuse disorders. Br J Pharmacol 176(17):3085–3109. https://doi.org/10.1111/bph.14780

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370(9600):1706–1713. https://doi.org/10.1016/s0140-6736(07)61721-8

Article  CAS  PubMed  Google Scholar 

Colombo G, Agabio R, Fà M, Guano L, Lobina C, Loche A, Reali R, Gessa GL (1998) Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol 33(2):126–130. https://doi.org/10.1093/oxfordjournals.alcalc.a008368

Article  CAS  PubMed  Google Scholar 

Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MM, Gessa L (2002) Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 159(2):181–187. https://doi.org/10.1007/s002130100887

Article  CAS  PubMed  Google Scholar 

Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U (2003) Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 27(3):289–301. https://doi.org/10.1038/sj.ijo.0802250

Article  CAS  PubMed  Google Scholar 

Covington HE 3rd, Newman EL, Tran S, Walton L, Hayek W, Leonard MZ, DeBold JF, Miczek KA (2018) The urge to fight: persistent escalation by alcohol and role of NMDA receptors in mice. Front Behav Neurosci 12:206. https://doi.org/10.3389/fnbeh.2018.00206

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crabbe JC, Colville AM, Kruse LC, Cameron AJ, Spence SE, Schlumbohm JP, Huang LC, Metten P (2012) Ethanol tolerance and withdrawal severity in high drinking in the dark selectively bred mice. Alcohol Clin Exp Res 36(7):1152–1161. https://doi.org/10.1111/j.1530-0277.2011.01715.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crabbe JC, Ozburn AR, Metten P, Barkley-Levenson A, Schlumbohm JP, Spence SE, Hack WR, Huang LC (2017) High drinking in the dark (HDID) mice are sensitive to the effects of some clinically relevant drugs to reduce binge-like drinking. Pharmacol Biochem Behav 160:55–62. https://doi.org/10.1016/j.pbb.2017.08.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dulman RS, Zhang H, Banerjee R, Krishnan HR, Dong B, Hungund BL, Vinod KY, Pandey SC (2021) CB1 receptor neutral antagonist treatment epigenetically increases neuropeptide Y expression and decreases alcohol drinking. Neuropharmacology 195:108623. https://doi.org/10.1016/j.neuropharm.2021.108623

Article  CAS  PubMed  PubMed Central  Google Scholar 

Economidou D, Mattioli L, Cifani C, Perfumi M, Massi M, Cuomo V, Trabace L, Ciccocioppo R (2006) Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology 183(4):394–403. https://doi.org/10.1007/s00213-005-0199-9

Article  CAS  PubMed  Google Scholar 

Gallate JE, Saharov T, Mallet PE, McGregor IS (1999) Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370(3):233–240. https://doi.org/10.1016/s0014-2999(99)00170-3

Article  CAS  PubMed  Google Scholar 

Giuliano C, Goodlett CR, Economidou D, García-Pardo MP, Belin D, Robbins TW, Bullmore ET, Everitt BJ (2015) The novel μ-opioid receptor antagonist GSK1521498 decreases both alcohol seeking and drinking: evidence from a new preclinical model of alcohol seeking. Neuropsychopharmacology 40(13):2981–2992. https://doi.org/10.1038/npp.2015.152

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldstein DB (1972) An animal model for testing effects of drugs on alcohol withdrawal reactions. J Pharmacol Exp Ther 183(1):14–22

CAS  PubMed  Google Scholar 

Goldstein DB, Pal N (1971) Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 172(3980):288–290. https://doi.org/10.1126/science.172.3980.288

Article  CAS  PubMed  Google Scholar 

Hwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, Miczek KA (2011) Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol Clin Exp Res 35(11):1938–1947. https://doi.org/10.1111/j.1530-0277.2011.01545.x

Article  PubMed  PubMed Central  Google Scholar 

Hwa LS, Kalinichev M, Haddouk H, Poli S, Miczek KA (2014) Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice. Psychopharmacology 231(2):333–343. https://doi.org/10.1007/s00213-013-3245-z

Article  CAS  PubMed  Google Scholar 

Hwa LS, Nathanson AJ, Shimamoto A, Tayeh JK, Wilens AR, Holly EN, Newman EL, DeBold JF, Miczek KA (2015) Aggression and increased glutamate in the mPFC during withdrawal from intermittent alcohol in outbred mice. Psychopharmacology 232(16):2889–2902. https://doi.org/10.1007/s00213-015-3925-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janero DR, Makriyannis A (2009) Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin Emerg Drugs 14(1):43–65. https://doi.org/10.1517/14728210902736568

Article  CAS  PubMed  Google Scholar 

Kangas BD, Zakarian AS, Vemuri K, Alapafuja SO, Jiang S, Nikas SP, Makriyannis A, Bergman J (2020) Cannabinoid antagonist drug discrimination in nonhuman primates. J Pharmacol Exp Ther 372(1):119–127. https://doi.org/10.1124/jpet.119.261818

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koob GF (2015) The dark side of emotion: the addiction perspective. Eur J Pharmacol 753:73–87. https://doi.org/10.1016/j.ejphar.2014.11.044

Article  CAS  PubMed  PubMed Central  Google Scholar 

Korpi ER, Linden AM, Hytönen HR, Paasikoski N, Vashchinkina E, Dudek M, Herr DR, Hyytiä P (2017) Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors. Addict Biol 22(4):1022–1035. https://doi.org/10.1111/adb.12393

Article  CAS  PubMed  Google Scholar 

Kunos G (2020) Interactions between alcohol and the endocannabinoid system [10.1111/acer.14306]. Alcohol Clin Exp Res 44(4):790–805. https://doi.org/10.1111/acer.14306

Article  PubMed  PubMed Central  Google Scholar 

Litten RZ, Wilford BB, Falk DE, Ryan ML, Fertig JB (2016) Potential medications for the treatment of alcohol use disorder: an evaluation of clinical efficacy and safety. Subst Abus 37(2):286–298. https://doi.org/10.1080/08897077.2015.1133472

Article  PubMed  Google Scholar 

Mason BJ, Heyser CJ (2010) Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence. CNS Neurol Disord Drug Targets 9(1):23–32. https://doi.org/10.2174/187152710790966641

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mason BJ, Lehert P (2012) Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data. Alcohol Clin Exp Res 36(3):497–508. https://doi.org/10.1111/j.1530-0277.2011.01616.x

Article  PubMed  Google Scholar 

Melendez RI (2011) Intermittent (every-other-day) drinking induces rapid escalation of ethanol intake and preference in adolescent and adult C57BL/6J mice. Alcohol Clin Exp Res 35(4):652–658. https://doi.org/10.1111/j.1530-0277.2010.01383.x

Article  PubMed  PubMed Central  Google Scholar 

Miczek KA, Akdilek N, Ferreira VMM, Kenneally E, Leonard MZ, Covington HE (2022a) Excessive alcohol consumption after exposure to two types of chronic social stress: intermittent episodes vs. continuous exposure in C57BL/6J mice with a history of drinking. Psychopharmacology 239(10):3287–3296. https://doi.org/10.1007/s00213-022-06211-8

Article  CAS  PubMed  Google Scholar 

Miczek KA, Akdilek N, Ferreira VMM, Leonard MZ, Marinelli LR, Covington HE 3rd. (2022b) To fight or not to fight: activation of the mPFC during decision to engage in aggressive behavior after ethanol consumption in a novel murine model. Psychopharmacology 239(10):3249–3261. https://doi.org/10.1007/s00213-022-06208-3

Article  CAS  PubMed  Google Scholar 

Parsons LH, Hurd YL (2015) Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci 16(10):579–594. https://doi.org/10.1038/nrn4004

Article  CAS